AGC
ABBV icon

Aspen Grove Capital’s AbbVie ABBV Stock Holding History

Aspen Grove Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$567K Hold
2,252
– – 0.08% 104
2026
Q1 		$490K Hold
2,252
– – 0.1% 100
2025
Q4 		$515K Hold
2,252
– – 0.09% 94
2025
Q3 		$521K Sell
2,252
-210
-9% -$42.8K 0.09% 93
2025
Q2 		$457K Buy
2,462
+665
+37% +$124K 0.08% 122
2025
Q1 		$377K Buy
1,797
+201
+13% +$39.1K 0.07% 138
2024
Q4 		$284K Sell
1,596
-115
-7% -$21.1K 0.06% 152
2024
Q3 		$338K Sell
1,711
-94
-5% -$17.5K 0.07% 135
2024
Q2 		$310K Buy
1,805
+75
+4% +$12.4K 0.07% 144
2024
Q1 		$315K Buy
1,730
+106
+7% +$18.3K 0.09% 139
2023
Q4 		$243K Sell
1,624
-445
-22% -$64.9K 0.07% 148
2023
Q3 		$308K Buy
2,069
+505
+32% +$74.1K 0.11% 117
2023
Q2 		$211K Sell
1,564
-226
-13% -$33.1K 0.07% 174
2023
Q1 		$285K Buy
+1,790
New +$274K 0.12% 115

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Aspen Grove Capital's ABBV Position: Q2 2026 in Review

Aspen Grove Capital held its AbbVie (ABBV) position steady in Q2 2026 at 2,252 shares worth $567K. The position accounts for 0.08% of the portfolio, ranked #104.

Aspen Grove Capital first reported a position in ABBV in Q1 2023 and has held it in 14 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Aspen Grove Capital held 2,252 shares of AbbVie worth $567K as of Q2 2026.
  • Aspen Grove Capital left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.08% of Aspen Grove Capital's portfolio in Q2 2026, its #104 holding.
  • Aspen Grove Capital first reported a position in AbbVie in Q1 2023 and has held it in 14 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Aspen Grove Capital's 13F filing for Q2 2026, filed 14 Aug 2026.